A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine when Administered Concomitantly with GSK Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects 16-18 Years of Age.

Objective

Clinical Trial Details>>

Principal Investigator(s)
Rick Kooima, MD

Clinical Trial Categories

  • Pediatrics
Sponsor(s)
GlaxoSmithKline
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154